InterveXion Therapeutics LLC
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2004-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.intervexion.com
Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200
- Conditions
- Methamphetamine-dependenceMethamphetamine Abuse
- Interventions
- Other: Placebo
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- InterveXion Therapeutics, LLC
- Target Recruit Count
- 61
- Registration Number
- NCT05034874
- Locations
- 🇺🇸
Pillar Clinical Research, Richardson, Texas, United States
🇺🇸Woodlands International Research Group, Little Rock, Arkansas, United States
🇺🇸Artemis Institute for Clinical Research, San Diego, California, United States
Safety, Tolerability, and Pharmacokinetics of IXT-m200
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- InterveXion Therapeutics, LLC
- Target Recruit Count
- 9
- Registration Number
- NCT05027451
- Locations
- 🇺🇸
Clinilabs Drug Development Corporation, Eatontown, New Jersey, United States
Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose
- Conditions
- Methamphetamine Intoxication (Disorder)
- Interventions
- First Posted Date
- 2021-01-20
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- InterveXion Therapeutics, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT04715230
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸University of New Mexico Hospital, Albuquerque, New Mexico, United States
🇺🇸Providence Regional Medical Center Everett, Everett, Washington, United States
Study of Antibody for Methamphetamine Outpatient Therapy
- Conditions
- Methamphetamine-dependenceMethamphetamine Abuse
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2022-03-10
- Lead Sponsor
- InterveXion Therapeutics, LLC
- Target Recruit Count
- 77
- Registration Number
- NCT03336866
- Locations
- 🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸PRA Health Sciences, Salt Lake City, Utah, United States
Safety Study of Ch-mAb7F9 for Methamphetamine Abuse
- Conditions
- Methamphetamine Abuse
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2014-05-13
- Lead Sponsor
- InterveXion Therapeutics, LLC
- Target Recruit Count
- 42
- Registration Number
- NCT01603147
- Locations
- 🇺🇸
Quintiles Phase 1 Services, Overland Park, Kansas, United States